Suresh Durgam, MD, Receives ISCDD Leadership Award at Annual Meeting

Celebrating Excellence in CNS Drug Development

At the recent 24th Annual Meeting of the International Society for CNS Drug Development (ISCDD) held in Las Vegas, Dr. Suresh Durgam was awarded the prestigious ISCDD Leadership Award. This award, presented by Dr. Amir Kalali and Dr. Bill Martin, highlights Dr. Durgam's significant contributions in advancing treatments for central nervous system (CNS) disorders.

Dr. Durgam expressed his gratitude, stating, "I am honored to accept the ISCDD Leadership Award from an organization that embodies the forefront of CNS drug development. This recognition is not just mine but reflects the commitment of many dedicated professionals who have worked tirelessly alongside me to develop innovative treatments for serious mental health issues."

Dr. Kalali, a member of the ISCDD's Executive Committee, praised Dr. Durgam's impactful work across various companies, providing hope to countless patients affected by brain disorders. His acknowledgment underscores the importance of collaboration among researchers and clinicians in the complex landscape of CNS drug development.

Additionally, Dr. Bill Martin emphasized that few leaders have had such a transformative impact on psychiatric drug development as Dr. Durgam, highlighting his humility, technical prowess, and enduring contributions to the field. This recognition speaks volumes about his dedication to improving the lives of patients around the world.

Founded in 2002, the ISCDD serves as a vital independent forum that unites academia, industry, and government entities aimed at fostering collaboration in the drug development space. Through this assembly, they address pressing challenges and innovate solutions for CNS disorders, which affect millions globally.

The acknowledgment of Dr. Durgam aligns with ISCDD's mission to enhance the quality and accessibility of mental health treatments. As mental health continues to be a critical public health concern, initiatives like these underscore the urgent need for ongoing research and development in this area.

In accepting this award, Dr. Durgam not only reinforces the significance of teamwork in achieving breakthroughs but also inspires the next generation of leaders in CNS pharmacotherapy. His work exemplifies a commitment to pushing boundaries in drug development and ensuring that effective treatments reach patients who need them most.

The ISCDD continues to be a pivotal organization in fostering advancements in CNS drug development, and awards like the Leadership Award amplify the importance of recognizing the efforts of individuals making a difference in the field. As the demand for innovative mental health treatments grows, so does the necessity for leaders like Dr. Durgam, who pave the way for future breakthroughs.

For media inquiries about the ISCDD and Dr. Durgam's achievements, please contact the ISCDD Secretariat at 702-992-0784 or visit their official communications channels.